BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1118 related articles for article (PubMed ID: 32269046)

  • 1. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 3. Of chloroquine and COVID-19.
    Touret F; de Lamballerie X
    Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
    Juurlink DN
    CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
    [No Abstract]   [Full Text] [Related]  

  • 5. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
    Pimentel J; Andersson N
    Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covid-19 treatment update: follow the scientific evidence.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):43-53. PubMed ID: 32338320
    [No Abstract]   [Full Text] [Related]  

  • 8. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.
    Patil VM; Singhal S; Masand N
    Life Sci; 2020 Aug; 254():117775. PubMed ID: 32418894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
    Lentini G; Cavalluzzi MM; Habtemariam S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).
    Keshtkar-Jahromi M; Bavari S
    Am J Trop Med Hyg; 2020 May; 102(5):932-933. PubMed ID: 32247318
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
    White CM; Hernandez AV
    J Clin Pharmacol; 2020 Aug; 60(8):949-953. PubMed ID: 32530493
    [No Abstract]   [Full Text] [Related]  

  • 15. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
    Mvumbi DM
    Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging prophylaxis strategies against COVID-19.
    Agrawal S; Goel AD; Gupta N
    Monaldi Arch Chest Dis; 2020 Mar; 90(1):. PubMed ID: 32231348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 18. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
    Sargin G; Yavaşoğlu Sİ; Yavasoglu I
    Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
    [No Abstract]   [Full Text] [Related]  

  • 19. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
    Islam M
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.